VetStem CEO Joins ACRM Board of Directors
The American College of Regenerative Medicine (ACRM) has asked VetStem CEO, Dr. Bob Harman, to join their board of directors. As the CEO and co-founder of both VetStem and human subsidiary, Personalized Stem Cells, Inc. (PSC), Dr. Harman has nearly two decades of experience working with stem cells and regenerative medicine.
The first of its kind, the ACRM is a multi-specialty, interdisciplinary medical organization. The ACRM was formed to promote the science and ethical use of regenerative medicine with a strong emphasis on global interdisciplinary collaboration. Board members include medical doctors and surgeons, a dentist, a registered nurse and our very own veterinarian, Dr. Harman.
The ACRM’s mission statement encompasses everything from physician and patient education to safety and scientific advancement. While regenerative medicine and stem cell therapy is not new, there is still much to learn about regenerative cell therapies. The ACRM is fully committed to patient safety and a high standard of care. Like VetStem and PSC, the ACRM advocates for patient safety by following FDA guidelines and maintaining compliance.
The interdisciplinary focus of the ACRM will allow for the amalgamation of knowledge and expertise from doctors across multiple fields. Dr. Harman brings nearly two decades of experience with regenerative medicine in the veterinary field to share. With the launch of PSC in 2018, Dr. Harman can also provide insight into human regenerative medicine and FDA approved stem cell clinical trials. We hope this “One Medicine” approach will ultimately lead to understanding regenerative cell therapies more fully and open the door for additional FDA approved regenerative treatment options.